Drug Shortage Report for TEVA-SPIRONOLACTONE

Last updated on 2020-02-13 History
Report ID 1560
Drug Identification Number 00613223
Brand name TEVA-SPIRONOLACTONE
Common or Proper name TEVA-SPIRONOLACTONE 100MG TABLETS 100
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SPIRONOLACTONE
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C03DA
ATC description POTASSIUM-SPARING AGENTS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2017-03-01
Estimated end date
Actual end date 2020-02-12
Shortage status Resolved
Updated date 2020-02-13
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-02-13 French Compare
v9 2020-02-13 English Compare
v8 2017-10-10 French Compare
v7 2017-10-10 English Compare
v6 2017-07-26 French Compare
v5 2017-07-26 English Compare
v4 2017-07-26 French Compare
v3 2017-07-26 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare